Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Accuray Inc ARAY

Healthcare Medical Devices

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments.... see more

Add To Watchlist

Recent & Breaking News (NDAQ:ARAY)

New Reimbursement Approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife® System to Treat Trigeminal Neuralgia, a Condition Often Causing Severe Facial Pain

PR Newswire October 26, 2022

GE Healthcare and Accuray Collaborate to Expand Access, Advance the Practice of Precision Radiation Therapy

PR Newswire October 21, 2022

Accuray to Report First Quarter Fiscal 2023 Financial Results on November 2, 2022

PR Newswire October 19, 2022

Accuray and C-RAD Unveil Automated Breast Cancer Treatment Package for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting

PR Newswire October 13, 2022

Data Published in The Lancet Oncology Indicate Men With Prostate Cancer Treated With the Accuray CyberKnife® Platform Experienced a Lower Incidence of Bladder Side Effects Than Those Treated With Conventional Linear Accelerators

PR Newswire October 11, 2022

Accuray to Host Meeting with Analysts and Investors at ASTRO on October 24, 2022

PR Newswire October 6, 2022

Accuray Announces First CyberKnife® Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients

PR Newswire September 30, 2022

Dr. Seth Blacksburg Joins Accuray as VP, Chief Medical Officer Americas Region

PR Newswire September 14, 2022

Accuray Partners with Swiss-based Genolier Innovation Hub to Bring Medical and Technological Advances to Patients Faster

PR Newswire September 7, 2022

Accuray Reports Fourth Quarter and Fiscal 2022 Financial Results

PR Newswire August 10, 2022

Accuray to Report Fiscal Year-End 2022 Financial Results on August 10, 2022

PR Newswire July 27, 2022

Accuray CyberKnife® System Real World Data and Clinical Studies Show Benefits in Treatment of Neurological Indications

PR Newswire July 12, 2022

Accuray Appoints Franco N. Palomba as VP, Chief Accounting Officer & Controller

PR Newswire June 15, 2022

Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules

PR Newswire June 6, 2022

Accuray and Limbus AI Inc. Partner to Leverage Limbus' Innovative AI-driven Technology to Enhance Accuray Adaptive Radiotherapy Solutions

PR Newswire June 2, 2022

Accuray Appoints Sandeep Chalke as SVP, Chief Commercial Officer

PR Newswire May 17, 2022

New Data Presented at ESTRO 2022 Reinforce Benefits of Accuray CyberKnife® and TomoTherapy® Platforms Across a Range of Indications and Complexities

PR Newswire May 10, 2022

Accuray ClearRT(TM) Helical Fan-Beam kVCT Imaging Wins "Best New Technology Solution for Oncology" MedTech Breakthrough Award

PR Newswire May 5, 2022

Accuray Reports Fiscal 2022 Third Quarter Financial Results

PR Newswire April 27, 2022

Accuray Announces Suzanne Winter, President, Promoted to President and CEO; Joshua Levine Will Retire as CEO and Board Member

PR Newswire April 27, 2022